India's Richest People 2026 edition · 1 director · Source: Hurun India
- #55 Manju D Gupta & family ₹50,000 Cr
Revenue · FY 2025
₹256.8 Cr
Latest filing
Net profit · FY 2025
₹9.31 Cr
Net margin 3.6%
EBITDA · FY 2025
₹16.41 Cr
EBITDA margin 6.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.35 Cr
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
4
As per MCA filings
Last financials
Mar 2026
Balance sheet date
About Lupin Life Sciences Limited
Data last updated:
Lupin Life Sciences Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 July 2023.
Its director Manju D Gupta and family are #55 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U86100MH2023PLC406793.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.35 Cr. It is led by directors including Swaminathan Ramesh and Nilesh Deshbandhu Gupta.
Its last annual general meeting (AGM) was held on 13 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹256.8 Cr. For the same year it recorded a net profit of ₹9.31 Cr (net margin 3.6%) and EBITDA of ₹16.41 Cr (EBITDA margin 6.4%).
Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 3 cases are pending.
For more details, the company can be reached via its website lupin.com.
Company details
CIN U86100MH2023PLC406793
Registration Number 406793
Incorporation Date 17 July 2023
ROC Mumbai
Listing Status Unlisted
Company Status Active
Key People
Swaminathan Ramesh Director Nilesh Deshbandhu Gupta Director Manju Deshbandhu Gupta Director Recognitions & Rankings of Lupin Life Sciences
Contact details
Lupin Life Sciences Limited's registered office is in Mumbai, Maharashtra. Its website is lupin.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Fl Kalpataru Inspire, Off Western E. Highway, Mumbai, Maharashtra, India – 400055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lupin Life Sciences Limited, buy the company report.
Comprehensive company report
Lupin Life Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lupin Life Sciences is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Lupin Life Sciences Limited, buy the company report.
Financials of Lupin Life Sciences Limited
FY 2026 filings availableLupin Life Sciences Limited reported revenue of ₹256.8 Cr for FY 2025.
Revenue · FY 2025
₹256.8 Cr
Net profit · FY 2025
₹9.31 Cr margin 3.6%
EBITDA · FY 2025
₹16.41 Cr margin 6.4%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹16.41 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹9.31 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 6.4% | |
| Net Profit Margin | 3.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lupin Life Sciences Limited, buy the company report.
Board of directors of Lupin Life Sciences Limited
Lupin Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swaminathan Ramesh Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Lupin Diagnostics Limited and 4 more | Director | 21 May 2025 | 1 Years 5 Months | Current |
| Nilesh Deshbandhu Gupta Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Lupin Diagnostics Limited and 5 more | Director | 17 Jul 2023 | 3 Years 3 Months | Current |
| Manju Deshbandhu Gupta Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Lupin Diagnostics Limited and 1 more | Director | 30 Jun 2026 | 0 Years 4 Months | Current |
| Rajeev Sibal | Director | 17 Jul 2023 | 3 Years 3 Months | Current |
Auditor
Lupin Life Sciences Limited is audited by B S R & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2024 | 101248W/W-100022 |
Legal cases
Lupin Life Sciences Limited has 3 court cases on record: 1 filed by Lupin Life Sciences, 2 filed against it. All cases are pending.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed by the company against M/S Shankar Medicos | Pending |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company | Pending |
To see the full case history of Lupin Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lupin Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lupin Life Sciences Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lupin Life Sciences Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Manju Deshbandhu Gupta was appointed as Director on 30 Jun 2026.
AGM
Lupin Life Sciences Limited last Annual general meeting of members was held on 13 Aug 2026 as per latest MCA records.
Appointed
Manju Deshbandhu Gupta was appointed as Director.
Filing
Lupin Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Ceased
Sunil Makharia ceased to be Director.
Appointed
Swaminathan Ramesh was appointed as Director.
Appointed
Nilesh Deshbandhu Gupta was appointed as Director.
Appointed
Rajeev Sibal was appointed as Director.
Incorporation
17 Jul 2023
Lupin Life Sciences Limited was registered on 17 Jul 2023 with Roc Mumbai I & aged 3 years 3 months as per MCA records.
News
Frequently asked questions
Lupin Life Sciences is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 July 2023 (3+ years old) and is registered under CIN U86100MH2023PLC406793.
Lupin Life Sciences has 4 current directors:
- Swaminathan Ramesh - Director
- Nilesh Deshbandhu Gupta - Director
- Manju Deshbandhu Gupta - Director
- Rajeev Sibal - Director
The latest financial statements of Lupin Life Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 13 August 2026. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Lupin Life Sciences is U86100MH2023PLC406793. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lupin Life Sciences has 3 court cases on record: 1 filed by the company and 2 filed against it. 3 are pending.
Lupin Life Sciences was incorporated on 17 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Manju Deshbandhu Gupta was appointed as Director on 30 Jun 2026. Sunil Makharia ceased to be Director on 21 May 2025. Swaminathan Ramesh was appointed as Director on 21 May 2025. Lupin Life Sciences has 5 board changes on record in total.
Lupin Life Sciences can be reached through the website lupin.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Lupin Life Sciences is at 3rd Fl Kalpataru Inspire, Off Western E. Highway, Mumbai, Maharashtra, India – 400055.
Lupin Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages